Purple Biotech Ltd.
PPBT | NASDAQ
$1.20
+$0.03 (+2.56%)
Nov 2, 2026, 10:34 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 236.65K |
Gross Profit | n/a | n/a | n/a | n/a | n/a | -236.65K |
Operating Income | -27.46M | -11.01M | -22.27M | -22.6M | -17.93M | -13.33M |
Interest Income | 227K | 260K | 474K | 532K | 320K | 255.78K |
Pretax Income | -26.49M | -7.28M | -19.98M | -21.76M | -17.83M | -28.9M |
Net Income | -26.39M | -7.24M | -19.88M | -21.67M | -18.38M | -28.2M |
Selling & General & Admin | 2.98M | 2.94M | 4.84M | 5.96M | 5.82M | 5.81M |
Research & Development | 3.73M | 7.62M | 17.03M | 16.32M | 11.83M | 7.29M |
Other Expenses | 20.74M | 450K | 393K | 321K | 286K | 1 |
Operating Expenses | 27.46M | 11.01M | 22.27M | 22.6M | 17.93M | 13.1M |
Interest Expense | 39K | 41K | 56K | 67K | 79K | 56.39K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.46M | 11.01M | 22.27M | 22.6M | 17.93M | 13.33M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 4.8M | 1.64M | 1.11M | 902.83K | 910.19K | 562.41K |
Shares Outstanding (Diluted) | 4.8M | 1.64M | 1.11M | 904.05K | 878.4K | 575.01K |
EPS (Basic) | -5.50 | -4.42 | -17.96 | -24 | -20 | -50 |
EPS (Diluted) | -5.50 | -4.42 | -17.96 | -24 | -20 | -50 |
EBITDA | -26.25M | -7.05M | -19.72M | -21.49M | -17.52M | -13.1M |
EBIT | -26.45M | -7.24M | -19.92M | -21.69M | -17.75M | -13.33M |
Depreciation & Amortization | 203K | 186K | 197K | 201K | 231K | 236.65K |
Add to Watchlist
Select watchlists to add or remove PPBT